IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Astria Therapeutics Inc (CATBUSD)

CUSIP: 04635X102 | XG | 276 institutional holders

Quarters

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/APerceptive Advisors LLC00.0%Fell below 5%Jan 26, 202626d ahead of 13F (6,485,420 sh) · −6,485,420
13D/AMagnetar Financial LLC00.0%Fell below 5%Jan 26, 202626d ahead of 13F (3,431,007 sh) · −3,431,007
13D/APerceptive Advisors LLC0
0.0% of class · Jan 26, 2026Fell below 5%
26d ahead of 13F (6,485,420 sh) · −6,485,420
13D/AMagnetar Financial LLC0
0.0% of class · Jan 26, 2026Fell below 5%
26d ahead of 13F (3,431,007 sh) · −3,431,007

Institutional Holders — Q1 2026

Vanguard Group Inc0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Vanguard Group Inc
0$00.0%N/AN/AValley Forge, PA2026-05-14